Target Price | $108.12 |
Price | $95.37 |
Potential |
13.37%
register free of charge
|
Number of Estimates | 11 |
11 Analysts have issued a price target LeMaitre Vascular, Inc. 2026 .
The average LeMaitre Vascular, Inc. target price is $108.12.
This is
13.37%
register free of charge
$126.00
32.12%
register free of charge
$92.92
2.56%
register free of charge
|
|
A rating was issued by 17 analysts: 10 Analysts recommend LeMaitre Vascular, Inc. to buy, 7 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the LeMaitre Vascular, Inc. stock has an average upside potential 2026 of
13.37%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 219.86 | 255.74 |
13.63% | 16.32% | |
EBITDA Margin | 26.40% | 28.87% |
17.99% | 9.36% | |
Net Margin | 20.03% | 20.61% |
28.71% | 2.89% |
13 Analysts have issued a sales forecast LeMaitre Vascular, Inc. 2025 . The average LeMaitre Vascular, Inc. sales estimate is
This results in the following potential growth metrics:
11 Analysts have issued an LeMaitre Vascular, Inc. EBITDA forecast 2025. The average LeMaitre Vascular, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
13 LeMaitre Vascular, Inc. Analysts have issued a net profit forecast 2025. The average LeMaitre Vascular, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 1.93 | 2.33 |
44.03% | 20.73% | |
P/E | 40.96 | |
EV/Sales | 7.85 |
13 Analysts have issued a LeMaitre Vascular, Inc. forecast for earnings per share. The average LeMaitre Vascular, Inc. EPS is
This results in the following potential growth metrics and future valuations:
LeMaitre Vascular, Inc....
Analyst | Rating | Action | Date |
---|---|---|---|
Barrington Research |
Locked
➜
Locked
|
Locked | Aug 06 2025 |
Cantor Fitzgerald |
Locked
➜
Locked
|
Locked | Aug 06 2025 |
Barrington Research |
Locked
➜
Locked
|
Locked | Jul 22 2025 |
Barrington Research |
Locked
➜
Locked
|
Locked | Feb 28 2025 |
Citizens Capital Markets |
Locked
➜
Locked
|
Locked | Feb 28 2025 |
Lake Street |
Locked
➜
Locked
|
Locked | Feb 28 2025 |
Wells Fargo |
Locked
➜
Locked
|
Locked | Feb 13 2025 |
Analyst Rating | Date |
---|---|
Locked
Barrington Research:
Locked
➜
Locked
|
Aug 06 2025 |
Locked
Cantor Fitzgerald:
Locked
➜
Locked
|
Aug 06 2025 |
Locked
Barrington Research:
Locked
➜
Locked
|
Jul 22 2025 |
Locked
Barrington Research:
Locked
➜
Locked
|
Feb 28 2025 |
Locked
Citizens Capital Markets:
Locked
➜
Locked
|
Feb 28 2025 |
Locked
Lake Street:
Locked
➜
Locked
|
Feb 28 2025 |
Locked
Wells Fargo:
Locked
➜
Locked
|
Feb 13 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.